Richard J. Kryscio, Erin L. Abner, Allison Caban-Holt, et al. Key Points Question Can vitamin E or selenium prevent dementia in asymptomatic older men? Findings The Prevention of Alzheimer’s Disease by Vitamin E and Selenium trial initially enrolled 7540 elderly men who were exposed to the supplements for an average [...]
Treatment with the diuretic bumetanide (Bumex, Validus) improved core symptoms of autism spectrum disorder (ASD), including social deficits and stereotyped behaviors, results from a multicenter phase 2b study show. Bumetanide was effective in improving ASD-related symptoms across the pediatric age range, as assessed by the Childhood Autism Rating Scale (CARS), [...]
The New York Times today reported that researchers writing for the journal, Nature, found that There are now thousands of fake open-access journals, about as many as legitimate ones. The authors created a fake 'Editor" that they then applied to numerous 'scientific journals.' The applicant’s nom de plume was not [...]
In findings reported in a letter to the editor published online March 10 in Schizophrenia Research and reported by Medscape Medical News, the smoking cessation drug varenicline (Chantix) appears to enhance cognition in nonsmoking individuals with and those without schizophrenia. The results also showed that the drug reduced the cognitive [...]
Carfentanil, an opioid said to be 100 times more powerful than fentanyl, has been tied to at least 700 deaths in numerous states. Worst hit include Michigan, Florida, and Ohio, according to data compiled by US authorities. Carfentanil was originally intended to sedate large animals, such as elephants, and is [...]
The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, according to a new study published in JAMA Internal Medicine and reported in today's New York Times. The new [...]
The latest edition of Psychopharmacology Bulletin is now available at: https://medworksmedia.com/product-category/psychopharmacology-bulletin/psychopharmacology-47-no-1/. Manuscripts include: Asenapine for the Control of Physical Aggression: A Prospective Naturalist Pilot Study By Jin Shi Amon, Sarah B. Johnson, Rif S. El-Mallakh A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae By Badari Birur, Suresh Bada Math, Rachel E. Fargason [...]
In a surprise to the conservative treatments by neurologists, tailored exercise treatment programs are being developed by physical therapists to specifically counter the unique movement impairments associated with Parkinson’s by training patients to make big strong movements that incorporate the principles of tai chi and boxing. Treatments can, as well, [...]
Deep brain stimulation, an established therapy that modifies the brain's circuitry to treat symptoms of depression, Parkinson's disease and other movement disorders, is attracting fresh attention from medical-device makers who believe it is underused. St. Jude Medical Inc. recently introduced a new DBS system in the U.S., and Boston Scientific [...]
Charles Marmar, a 71-year-old psychiatrist in New York, has spent his career studying post traumatic stress disorder, which has symptoms such as sleep disruption and vivid flashbacks of the traumatic experience. PTSD is often associated with war: Between 11% and 20% of veterans who served in Iraq and Afghanistan have [...]